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Severe mutilating recessive dystrophic epidermolysis bullosa 
presents with ex~ensive blistering, s~ar:i~g, and pseudosyn-
dactylies . The skm of most affected mdlvlduals lacks normal 
anchoring fibrils and contains no, or drastically reduced 
amounts of, collagen VII, the major fibril component. Here 
we present evi~ence ~or molecular heter.ogene~ty of the mu-
tations underlymg thIs phenotype. A patient wIth severe mu-
tilating disease, but with apparently normal anchoring fibrils 
and abundant collagen VII, was defined. Indirect immuno-
fluorescence examination of the patient's skin exhibited a 
strong staining for collagen VII at the dermo-epidermal 
junction and at the roof of a natural blister, and immunoblot-
ting of skin extracts revealed collagen VII of normal size. The 
D ystrophic epidermolysis bullosa (EED) is a geneti-cally and henotypically heterogeneous group of skin disorders characterized by blistering and scar. -ring after minor trauma [1- 3]. At least six sub-groups have been defined based on the mode of in-
heritance and distribution of the lesions, but in all of them the 
cleavage occurs below the basement membrane, at the level of the 
anchoring fibrils. Qualitative and quantitative abnormalities of the 
fibrils in patients' skin have been revealed by ultrastructural analysis 
[4 - 6], and aberrant expression of collagen VII, the major anchoring 
fibril protein, has been detected in several affected individuals [7-
11]. In line with these findings, genetic linkage was recently estab-
lished between the collagen VII gene, and both dominant and reces-
sive mutilating EED [12,13], further implying that collagen VII 
mutations cause these diseases. 
The most severe subtype ofEED is the recessively inherited gen-
eralized, mutilating EED [1- 3]. Extensive blistering leads to severe 
scarring and mutilation, often to secondary carcinomas and poor 
prognosis. Lack of i~tact anchoring fibr~ls .an~ collagen VI! from the 
skin has been descnbed as a charactenstlc SIgn of the dIsease [4-
9,14]' although some individuals exhibit small amounts of immu-
noreactive collagen VII at the dermo-epidermal junction [2,15] . 
Different pathways have been suggested to lead to lack of anchoring 
fibrils in this EED subtype. Impaired collagen VII synthesis was 
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patient's keratinocytes expressed two- to threefold increased 
amounts of collagen VII at the mRNA and protein level 
compared to controls. Synthesis of matrix metalloproteases 
by the patient's keratinocytes was comparable to normal 
cells, indicating that the overexpression of collagen VII did 
not affect the synthesis of these enzymes. We hypothesize 
that in this patient a mutation affecting interactions of the 
anchoring fibrils with other components of the basement 
membrane zone underlies the disease. Key words: anchoring 
fibrils/basemwt membratte/bullous disease/dermo-epidermal junc-
tion/matrix metalloproteases. ] Invest Dermatol 102:155 -159, 
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observed in some patients [16] and elevated collagenolytic activity 
in fibroblasts of others [17,18]. 
To elucidate the mechanisms underlying the severe phenotype in 
mutilating EED, we assessed collagen VII expression in skin and 
cells derived from several patients. The clinically uniform patients 
showed ultrastructural and molecular heterogeneity. Whereas most 
probands had no or drastically reduced amounts of collagen VII in 
skin, the present propositus, a severely affected patient, had appar-
ently normal anchoring fibrils and exhibited strong collagen VII 
immunofluorescence staining. We have now extended the studies 
on this patient and show that cultured keratinocytes overproduce 
collagen VII whereas the synthesis of matrix metalloproteases 
(MMP) appears normal. 
MATERIALS AND METHODS 
Paticnt The 20-year-old male Norwegian proband (EB 79-1) is an 
adopted child, but extensive genealogy of the biologic ancestries ruled out 
consanguinity. He suffered from blistering of the skin since birth and a 
severe course of the disease ending in extensive synecchias that needed 
repeated plastic surgery and contractures that led to partial wheelchair de-
pendency [19]. The patient thus presented with a characteristic phenotype of 
severe mutilating recessive EBD, with affection of the skin and mucous 
membranes but not of other organs. Diagnostic electron microscopy showed 
sublamina densa splitting in spite of the presence of numerous normal an-
choring fibrils in intact skin, and antigen mapping revealed strong fluores-
cence with antibodies to collagen VII [5] .t New biopsies were obtained from 
clinically uninvolved skin and roofs of fresh trauma-induced blisters were 
removed for keratinocyte cultures. 
Ccll Cultures Keratinocytes were obtained by trypsinization of control 
skin biopsies or fresh blister roofs and cuItured in serum-free keratinocyte 
t Winberg J-O, Anton-Lamprecht I, Konig A, Bruckner-Tuderman L, 
Gedde-Dahl T (manuscript in preparation). 
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growth medium containing 0.09 mM calcium [20) (KGM; Gibco, Grand 
Island, NY), supplemented with bovine pituitary extract (BPE) and epIder-
mal growth factor (EGF). EBD and no~mal c~lls. fro~ early passages were 
used for the experiments. Two d~ys pnor to mduect Immunoflu.orescence 
(IF) staining or extraction ofkeratmocytes, BPE and ~GF were omitted from 
the medium, and 50 Ilg/ml ascorbate was added dally. 
For determination of MMP synthesis, keratinocytes were seeded in 6-well 
plates in KGM. One batch of each cell line was used in a conflue~t and t.he 
other in a preconfluent state. Each culture was washed three times with 
Hanks' solution and incubated for 24 h in 1.5 ml ofKGM without BPE and 
EGF. To one aliquot of the harvested medium, a gelatinase buffer concen-
trate was added to give a final concentration of 0.2% bovine serum albumin 
(BSA), 100 mM Hepes, pH 7.2, and 10 mM CaCI2, and to another aliquot a 
collagenase buffer concentrate to give a final concentration of 100 mM 
Hepes, pH 7.2, and 10 mM CaCI2 .. T.he buffered media were stored at 
-20·C until use. To correct for vanatlon m the cell content, DNA was 
measured in each cell layer [21). A minimum of three parallel measurements 
per strain were performed. The average variability was less than 5%. 
Antibodies and IF Staining Polyclonal affinity-purified antibodies to 
the triple helical domain of human collagen VII were prepared as described 
[22). The monoclonal antibody LH-7 .2 [23) to th~ N-terminal. globular 
domain of collagen VII was purchased from Chemlcon International Inc. 
(Temecula, CA). Polyclonal antibodies to ~uman la~inin were. a gen~rous 
gift from Dr. M. Paulsson, M.E. Muller Institute for BlOmechamcs, Uruver-
sity of Berne, a monoclonal antibody to collagen IV from Dr. B. Odermatt, 
Department of Pathology, University of Zurich, and a monoclonal antibody 
to kalinin from Dr. R. Burgeson, Harvard Medical School, Boston, MA. As a 
bullous pemphigoid antibodies, a high-titer serum from a patient was used. 
The fluorescein isothiocyanate (FITC) -labeled anti-rabbit, anti-mouse, and 
anti-human antibodies were obtained from Dakopatts, Glostrup, Denmark, 
and peroxidase-labeled goat anti-rabbit antibodies were from Kirkegaard & 
Perry, Gaithersburg, Maryland. Cryosectlons (5 Ilm) of normal or EBD skm, 
or semiconfluent keratino~tes on g!ass coversli,Ps, w~re permea?iliz~d and 
fixed in methanol for 15 mm at - 20 C. IncubatIOn With first antibodies was 
performed overnight, and with second antibodies for 1 h at room tempera-
ture. 
Collagen vn Extraction and Immunoblotting For extraction of col-
lagen VII, normal and EBD keratinocytes were seeded in 25-cm2 flasks and 
cultured to early confluency. Fotty-eight hours prior to extraction, BPE and 
EGF were omitted, and the medium was not changed, but 50 Ilg/ml ascor-
bate was added daily. The medium was then harvested on ice, and proteinase 
inhibitors were added to a final concentration of 1 mM phenylmethane-sul-
fonyl fluoride, 10 mM ethylenediamine tetraacetic acid (EDTI\,)! 20 mM 
N-ethylmaleimide, and 100 mM e-aminocaproic acid. After precipitation 
with 75% (v/v) ethanol at -20·C overnight and centrifugation with 
17,000 X gat O·C for 30 min, the pellet was dissolved in 200 III of~uf!er 
containing 8 M urea, 2% sodium dodecyl sulfate (SDS), 0.1 M l ,4-dlthlO-
erythritol, and 0.1 M Tris-HCI (pH 6.8). The cell layer was directly solubi-
lized in 200 III of the above exttaction buffer. The extracts were heated at 
100·C for 5 min, and extensively dialyzed against SDS-polyacrylamide gel 
electrophoresis (PAGE) sample buffer containing 0.8 M urea, 0.1 M Tris, pH 
6.8,2% SDS, 0.005% bromphenol blue, and 5% glycerine. After dialysis, the 
volumes were adjusted to the largest sample volume. 
Extraction of collagen VII from skin was performed as described earlier 
[22,24). Briefly, clinically unin:-,o.lved skin of the patient and.a contro~ was 
incubated in 1 M NaCI contalrung buffer supplemented With protemase 
inhibitors for 48 h. This treartnent induces splitting through the lamina 
lucida [25). The epidermis was then mechanically separated from the dermis, 
and both skin layers were extracted with 400 IlI/cm2 of the above extraction 
buffer for 2 min at 95· C, and the extracts were extensively dialyzed against 
SDS-PAGE sample buffer. 
The samples were separated by SDS-PAGE [26) under reducing condi-
tions, with a 4.5 -15% polyacrylamide gradient. The same amount of extract 
was loaded in each well. After e1ectrotransfer onto nitrocellulose [27) in the 
presence of o. ~ % SI?S, and blocki.ng of non-specific b.inding si~es with 2% 
milk powder III Tns-buffered sal me (TBS) for 30 mm, the rutrocellulose 
sheet was incubated with antibodies to collagen VII overnight and with 
peroxidase-labeled goat anti-rabbit IgG for 2 h. 4-chloro-l-naphtol was used 
as chromogen. 
Semiquantitative Enzyme-Linked Immunoassay for Collagen 
vn Due to extensive insolubility and tendency to aggregation of collagen 
VII in physiologic solutions, such as cell culture medium, common quanti-
tative immunoassays were not reproducible in our hands. Therefore, we 
utilized for quantitation of collagen VII in keratinocyte cultures a recently 
developed solid phase immunoassay that is based on extraction of proteins 
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Figure 1. Immunofluorescence staining of the patient's skin with antibod_ 
ies to collagen VII. A) Intact dermo-epidermaljunction with strong linear 
fluorescence. B) Blister roof; note the fluorescence at the basal aspect of the 
epidermis. Asterisk, blister cavity. 
with a chaotropic buffer, immunoblotting, and measurement of the anti_ 
body-bound peroxidase activity with a water-soluble chromogen [28] . 
After the separation of culture extracts with SDS-PAGE, transfer onto 
nitrocellulose, and reaction with the first and second antibodies, lanes with 
collagen VII standards were separated and reacted with water-insoluble 
4-chloro-l-naphtol. The migration position of collagen VII on the non_ 
reacted lanes was marked with help of these standards, and the correspond_ 
ing bands were excised and transferred to Eppendorf tubes. They were 
incubated in 0.5 ml of a substrate solution containing 0.03% o-phenylenedi_ 
amine, 25 mM citric acid, 50 mM Na2HP04' and 0.01 % hydrogen peroxide 
for 15 min. The reaction was stopped by adding 100 III of2 M sulfuric acid. 
The residual filter-bound color product was eluted with 200 III of 
N,N-dimethyl formamide, and both chromophore solutions were com-
bined prior to reading the absorbance at 492 nm. For calibration,S - 30 III of 
collagen VII containing dermal exttact were run on the same gel and mea-
sured in the same assay, parallel with the test satnples. Due to the semiquan_ 
titative nature of this assay, arbitrary units for collagen VII were defined. 
One unit corresponded to the amount of collagen VII present in 1 III of 
dermis extract that was prepared by using 400 III of extraction buffer per cm2 
of skin surface, as described above [22,24). Application of 5-30 III of skin 
extract as a standard resulted in a linear response in the assay. All cell culture 
samples were measured as duplicates in the linear range of the calibration 
curve. 
Northern and Southern Blotting Poly A+ RNA was isolated from ke-
ratinocyte cultures using a Pharmacia QuickPrep mRNA Purification Kit 
(Pharmacia LKB Biotechnology Division, Dubendorf, Switzerland) follow_ 
ing the instructions of the manufacturer. mRNA (1- 3 Ilg per well) was 
separated on a 1 % agarose gel containing 2.2 M formaldehyde, vacuum 
transferred onto a Nyttan nylon filter (Schleicher & Schuell, Dassel, Ger-
Figure 2. EBD keratinocytes overexpress collagen VII. IF staining with 
antibodies to the triple-helical domain of collagen VII of normal (A) and 
EBD (B) keratinocytes grown on coverslips. 
















Figure 3. Immunoblotting of collagen VII from EBD skin and keratino-
eyte extracts. Extracts were prepared as described in Materials alld Methods, 
and equal amounts ofEBD and control culture extracts were loaded. Lalles: 
1) standard. triple-helix of collagen VII. apparent MW 170 kD; 2) collagen 
VII from normal dermis, apparent MW 250 kD, using collagenous MW 
standards; 3) EBD dermis extract; 4) EBD epidermis extract; 5) control 
keratinocytes. cell layer; 6) control keratinocytes. medium; 7) EBD kerati-
nocytes. cell layer; 8) EBD keratinocytes, medium. The collagen VII signal 
is stronger in extracts of EBD cells and medium than of controls. Parallel 
immunoblots were run for a semiquantitative assay. The results are shown in 
Table I. 
many), and immobilized with VV linking (Stratalinker, Stratagene, Heidel-
berg, Germany). The filters were pre hybridized and hybridized [29] with 
radiolabeled collagen VII eDNA K131 [30], which was a generous gift from 
Dr. Jouni Vitto. Jefferson Medical College, Philadelphia, Pennsylvania. A 
eDNA of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [31]. a 
ubiquitous housekeeping gene. was used as a reference probe to correct for 
differences in RNA loading. The relative amount of collagen vn mRNA in 
EBD and control cells was determined by scanning the X-ray film of the 
Northern blot on a Hoefer GS 300 Scanning Densitometer. An average of 
three to four scans per lane at slightly different positions were performed, 
and the area of collagen VII signals relative to GAPDH signals was deter-
mined on the GS 365 Data System (Hoefer Scientific Instruments, San 
Fransisco, CAl· 
Southern blotting [29] was carried out with the K131 eDNA [30] on 
genomic DNA after digestion with the restriction enzyme Pvu II 
(Boehringer-Mannheim, Buchs, Switzerland). 
Matrix Metalloprotease (MMP) Activities The MMPs are secreted 
into culture medium in a latent form, and were converted to active forms by 
limited proteolysis using trypsin [32-34]. Collagenase activity was deter-
mined with reconstituted "C-labeled rat tail collagen fibrils as substrate [34]. 
The gelatinase substrate was denatured 3H-Iabeled calf skin collagen [33]. 
All assays, in at least triplicates. were carried out for 24 h in 0.1 M Hepes 
buffer, pH 7.5 at 35'C. The data were expressed as mean ± standard devia-
tion and analyzed using one-way analysis of variance (ANOV A). 
RESULTS 
Antigen Mapping IF staining of clinically uninvolved skin with 
antibodies to both the triple-helical and the N-terminal domain of 
collagen VII revealed a strong fluorescence at the basement mem-
brane zone (Fig IA). In a blister roof, the linear fluorescence was 
localized to the basal border of the epidermis (Fig IB), confirming 
the diagnosis of EBD. Antibodies to other basement membrane 
components, collagen IV, laminin, kalinin, and bullous pemphigoid 
antigen showed a normal staining, and localized to the blister roof 
in separated areas. 
Collagen VII Expression in Skin and Cultured Keratiocytes 
IF staining of cultured keratinocytes revealed a stronger fluores-
cence of collagen VII in the patient's cells than in controls (Fig 2). 
To allow for a better characterization of this increased collagen VII 
content in the cell cultures, confluent keratinocytes and their media 
were extracted and immunoblotted. Both EBD keratinocytes and 
their media contained more collagen VII than controls (Fig 3), 
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Table I. Collagen VII Expression by Normal and EBD 


































0.33 ± 0.05 2.77 ± 0.40 
0.65 ± 0.10 6.04 ± 1.44 




• The amount of collagen VII in a confluent 25 cm2 culture was determined using a 
solid-phase immunoassay based on immunoblotting with a water-soluble chromophore 
substrate (28). As a calibration standard. collagen VII containing dermal extract was 
used. One arbitrary unit of collagen VII (U) was defined as the amount present in 1 pi of 
skin extract prepared as described in detail (28J. 
I The relative amount of mRNA was estimated by densitometry of Northern blot 
autoradiographs. The analysis was performed using mRNA from three different cul-
tures of EBO 79-1 and from several keratinocyte cultures of normal individuals. This 
table shows two representative experiments. The results shown in Experiment 1 are 
from single cell cultures and those in Experiment 2 from duplicate cultures. For each 
lane, the amount of collagen VII mRNA was normalized to the signal obtained with 
GAPDH (see Materials and Methods). The average results of the different scans are 
presented as mean ± so. The different intensity of the scanning signals in Experiments 
1 and 2 is due to slightly different hybridization conditions. 
, Another BBD mutilans patient. This individual's skin was devoid of collagen VII. 
implying that the EBD cells synthesized and secreted more of this 
collagen. Semiquantitative measurement using the enzyme-linked 
immunoassay [28J showed a two- to threefold higher content of 
collagen VII in the EBD cultures (Table I) . There was no evidence 
for intracellular retention, as the ratio of cell layer associated versus 
secreted soluble collagen VII remained constant in both cultures 
(Table J). 
The patient'S dermis contained collagen VII of normal size. The 
amount was comparable to that in control skin, and a quantitative 
increase, if any, was not as apparent as in keratinocyte cultures (Fig 
3). Like in the control, treatment with 1 M NaCI buffer induced 
separation through the lamina lucida in the EBD skin, as collagen 
VII was found only in the dermal but not in the epidermal extracts. 
In contrast, trauma-induced blisters would show collagen VII at-
tached to the epidermis (see Fig IB) . 
In Northern blots only a single mRNA species was found in 
normal and EBD keratinocytes (Fig 4). Radiolabeled collagen VII 
cDNA hybridized with an abollt 8.5-kilobase (kb) mRNA in prepa-
rations of either source. However, the signal obtained with the EBD 
cell mRNA was clearly stronger than that from the controls. Scan-
ning of the autoradiographs revealed an about twofold increase in 
the amount of collagen VII mRNA in ED cells (Table J). The 
Northern analysis was performed with mRNA from three different 
cultures of the proband's keratinocytes, using mRNA from several 
keratinocyte cultures from different healthy unaffected individuals 
as controls. As an additional control, mRN A from an EBD mutilans 
patient who lacked collagen VII from the skin but showed mRNA 
levels comparable to healthy individuals was used. 
Southern hybridization of the patient's genomic DNA digested 
with the restriction endonuclease Pvu II demonstrated the AB 
genotype as defined by Ryynanen et af [12], but no aberrant frag-
ments. 
MMP Synthesis in Cultured Keratinocytes The synthesis of 
collagenase and gelatinase was determined in high- and low-density 
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Figure 4. Northern blotting of collagen VII mRNA from control and EBD 
keratinocytes. A) 1.5 and 3 f.lg mRNA from normal keratinocytes (Iatles 1 
and 2), and from EBD cells (lanes 3 and 4) were loaded. The filter was 
hybridized first with the K131 collagen VII cDNA [30] (top), and rehybri-
dized with a GPDHA cDNA (lower panel). B) Densitometric scans of lane 4 
(EB) and latle 2 (Co) of the above blot. Peak 1 results from the collagen VII 
mRNA band and peak 2 from the GAPDH band. 
cultures. As shown in Table II, low-density cultures produced more 
MMP than high-density cultures, but EBD cells did not produce 
more MMP than controls. High-density, but not low-density, cul-
tures of the patient showed an increased gelatinase activity. 
DISCUSSION 
Morphologically and immunochemically, the mutilating EBD has 
been defined by absence or dramatic reduction of anchoring fibrils 
and collagen VII from skin [1-9]. Our recent studies have demon-
strated that at least in some individuals, impaired synthesis of colla-
gen VII underlies this phenotype, as cultured EBD keratinocytes 
neither synthesized detectable amounts of collagen VII, nor could 
they be stimulated with TGF-p to do so [16] . In concert with this 
finding, Hilal et al reported mutations in the collagen VII gene in 
four patients with recessive mutilating EBD.§ Three mutations led 
to a premature stop codon in the 5' gene region coding for the 
N-terminal globular domain of collagen VII, thus providing an 
explanation for lack of a protein product. 
Here we present evidence for extensive molecular heterogeneity 
of this disorder. A patient with a typical severe phenotype of muti-
lating EBD, but with overexpression of apparently normal collagen 
VII, was defined. Collagen VII production in EBD keratinocytes 
was rwo- to threefold higher, at both protein and mRNA level, than 
in controls. The constellation agrees with the presence of numerous 
anchoring fibrils in the patient's skin in silll. 
It should be pointed out that the molecular type ofEBD described 
here may only be present in a small minority of recessive EBD 
mutilans patients. A dominant mutation of some sort cannot be 
totally excluded in the present propositus, because these patients 
rarely reproduce to disclose the inheritance. However, on one side 
his ancestry is rural and closely associated with the inbred ancestry 
of another EBD patient with generalized non-mutilating recessive 
EBD [19] . This fact not only supports recessive inheritance for the 
§ Hilal L, Hovnanian A, Duquesnoy P, Blanchet-Bardon C, Christiano 
AM, Vitto J, Goossens M: (abstr). ] Itlvest DermatoI100:499, 1993. 
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Table n. Matrix Metalloprotease Expression by Normal and 
EBD Keratinocytes In Vitro· 
Cell Collagenase Gelatinase 
Cells Density (mUff.lg DNA) (nmoljhjmg DNA) 
EBD LDb 93± 34 214 ± 6 
HD 12 ± 1 95 ±7 
Controls 
KC1 LD 99 ± 35 242 ± 24 
HD 25 ± 10 ND 
KC2 HD 65 ± 1 16 ± 2 
KC3 HD 63 ± 9 30±7 
KC4 HD 45 ±7 24±2 
• The collagenase and gelatinase activities arc expressed as mean ± SO. 
b Abbreviations: LO, low-density; HO, hjgh-density; KC, control keratinocytes, 
1-4 are cells derived from four different healthy adult individuals; NO, not deter_ 
m;ned. 
present patient, but also leads to interesting predictions, which can 
be tested on the other prototype homozygous patient [19]. Given 
the ancestry of the present patient, the possibility also exists that he 
is a compound heterozygote carrying rwo different mutations. 
The disturbed cohesion of the dermo-epidermal junction in the 
present case may be due to a mutation in the collagen VII gene but 
also may involve any abnormality of any basement membrane com-
ponent. The dermo-epidermal junction consists of an integral net-
work of structural macromolecules and depends strongly on physi-
cal and chemical interactions for both its architecture and its 
function. A structural defect of any component may perturb a spe-
cific interaction, and lead to a particular clinical phenotype. For 
instance, basement membrane or anchoring plaque proteins that 
bind collagen VII, such as collagen IV [35], can be considered as 
candidate molecules. A mutation in the collagen VII binding do-
mains of these proteins may cause dysfunction at the dermo-epider_ 
mal junction and thus lead to EBD, but not affect other organs. 
Alternatively, a yet-unknown component of the basement mem-
brane zone may be affected. 
Excessive degradation of the anchoring fibrils by collagenolytic 
enzymes is not the primary event in this proband because both 
anchoring fibrils and intact collagen VII were present in ample 
amounts. In addition, collagenase activity was similar in both EBD 
and control cells. Further studies must show whether the increased 
gelatinolytic activity in high-density cultures of the patient's cells is 
causally relevant, especially in regard to the apparently intact an-
choring fibrils. 
Interestingly, cultured EBD keratinocytes expressed more appar-
ently normal collagen VII than controls. Analogous overexpressioll 
has been observed in other heritable connective tissue disorders [36], 
but the nature of the signals leading to this phenomenon have re-
mained elusive and require further investigation of the regulation of 
gene expression of extracellular matrix components. 
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